|
|
|
|
|
|
Description:
DESCRIPTION:
PUREVAX™ Feline 4 contains a lyophilized suspension of modified live feline
rhinotracheitis, calici, and panleukopenia viruses and Chlamydia psittaci,
each propagated in a stable cell line, plus sterile water diluent. Safety and
immunogenicity of this product have been demonstrated by vaccination and
challenge tests in susceptible cats.
INDICATIONS:
PUREVAX™ Feline 4 is recommended for the vaccination of healthy cats 6 weeks
of age and older for prevention of disease due to feline rhinotracheitis, calici,
and panleukopenia viruses and as an aid in the reduction of disease due to Chlamydia
psittaci.
DOSAGE:
Reconstitute the lyophilized vaccine with accompanying liquid diluent and
aseptically inject 1 mL (1 dose) subcutaneously or intramuscularly into healthy
cats. For primary vaccination, revaccinate with a second 1 mL dose 3 to 4 weeks
later. Cats younger than 12 weeks of age should be revaccinated with a single 1
mL dose every 3 to 4 weeks, the last dose given at or over 12 weeks of age.
Revaccinate annually with a single 1 mL dose.
PRECAUTIONS:
Store at 2-7°C (35-45°F). Use immediately after reconstitution. Do not use
chemicals to sterilize syringes and needles. Burn the container and all unused
contents. Contains gentamicin as a preservative. Do not vaccinate pregnant cats.
In rare instances, administration of vaccines may cause lethargy, fever, and
inflammatory or hypersensitivity types of reactions. Treatment may include
antihistamines, anti-inflammatories, and/or epinephrine.
|